Table 1

Baseline characteristics and therapy of study participants according to diabetic state
Non T2DM(n = 6474) T2DM(n = 820) P-value
Females, % 27.1 43.1 <0.001
Age 62.3 ± 12.0 64.7 ± 9.9 <0.001
Systolic blood pressure 126.5 ± 25.1 128.1 ± 26.0 0.039
Admission heart rate 77.2 ± 17.8 82.2 ± 19.9 <0.001
Anterior ST Elevation, % 53.4 52.6 0.633
Killip class II-IV, % 17.1 24.8 <0.001
Glucose Level, mmol/L 7.9 ± 3.6 13.2 ± 5.5 <0.001
Previous medical history
Hypertension, % 38.5 57.4 <0.001
Myocardial Infarction, % 7.5 12.2 <0.001
Heart failure, % 2.2 6.3 <0.001
Stroke, % 8.4 16.5 <0.001
Therapeutic measures
PCI, % 10.9 16.9 <0.001
Thrombolytic therapy 53.3 45.1 <0.001
Insulin 11.5 40.2 <0.001
β-blockers, % 62.1 63.3 0.506
ACEI, % 71.8 73.3 0.367
Lipid-lowering drugs, % 71.1 72.6 0.377

PCI, percutaneous coronary intervention; ACEI, Angiotensin-converting enzyme inhibitors.

Han et al.

Han et al. BMC Cardiovascular Disorders 2012 12:104   doi:10.1186/1471-2261-12-104

Open Data